EUVIMEDEUVIMED entdecken
KommentarOpen Access

Suppression of MAP4K4 Signaling Ameliorates Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis-Molecular Studies Toward New Therapeutics

Michelle E Watts iD, Chen Wu, Lee L Rubin

Journal of Experimental Neuroscience · 2019-01 · 13

DOI: 10.1177/1179069519862798 ↗

Kurz gefasst

Kommentar in der Zeitschrift Journal of Experimental Neuroscience, online erschienen am 10.07.2019. Verfasst von Michelle E Watts und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyotrophic lateral sclerosis (ALS), the most common motor neuron (MN) disease of adults, is characterized by the degeneration of upper MNs in the motor cortex and lower MNs in the brain stem and spinal cord. Our recent work suggests that a MAP kinase family member, MAP4K4 (mitogen-activated protein kinase kinase kinase kinase 4), regulates MN degeneration in ALS. Activation of MAP4K4 occurs prior to MN death and inhibition of MAP4K4 improves neurite integrity and neuronal viability in a cell autonomous manner. The mechanism through which MAP4K4 reduction specifically modulates MN viability can be attributed to the attenuation of the c-Jun apoptotic pathway, as well as to the activation of FoxO1-mediated autophagy that reduces the accumulation of protein aggregates. We additionally show the feasibility of MAP4K4 as a drug target using a MAP4K4-specific inhibitor, which improves the survival of both primary and induced pluripotent stem cell (iPSC)-derived MNs. Our studies are thus far the first to highlight a MAP4K4-initiated signaling cascade that contributes to MN degeneration in ALS, providing a new mechanism underlying MN death in disease and a druggable target for new therapeutics. We propose exciting future directions and unexplored avenues based upon this work.

Schlagwörter

Stichwörter der Autor:innen

MAP4K4amyotrophic lateral sclerosis (ALS)apoptosisautophagyinduced pluripotent stem cell (iPSC)motor neuronneuritesurvival

Autor:innen und Institutionen

  • Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.

ORCID-Profile: Michelle E Watts

Zitieren

APA

Watts, M. E., Wu, C., & Rubin, L. L. (2019). Suppression of MAP4K4 Signaling Ameliorates Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis-Molecular Studies Toward New Therapeutics. Journal of Experimental Neuroscience, 13. https://doi.org/10.1177/1179069519862798

Vancouver

Watts ME, Wu C, Rubin LL. Suppression of MAP4K4 Signaling Ameliorates Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis-Molecular Studies Toward New Therapeutics. Journal of Experimental Neuroscience. 2019;13. doi:10.1177/1179069519862798

BibTeX
@article{Watts2019,
  author = {Watts, Michelle E and Wu, Chen and Rubin, Lee L},
  title = {Suppression of MAP4K4 Signaling Ameliorates Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis-Molecular Studies Toward New Therapeutics},
  journal = {Journal of Experimental Neuroscience},
  year = {2019},
  volume = {13},
  doi = {10.1177/1179069519862798}
}
Kostenlos starten →